 | | DRUG: Cromolyn sodium | |
| Entry |
|
|---|
| Name |
Cromolyn sodium (USP);
Sodium cromoglicate (JP18);
Gastrocrom (TN);
Intal (TN) |
|---|
| Product |
|
|---|
| Generic |
CROMOLYN SODIUM (A-S Medication Solutions), CROMOLYN SODIUM (Ailex Pharmaceuticals), CROMOLYN SODIUM (Bryant Ranch Prepack), CROMOLYN SODIUM (Bryant Ranch Prepack), CROMOLYN SODIUM (Bryant Ranch Prepack), CROMOLYN SODIUM (Micro Labs Limited), CROMOLYN SODIUM (Micro Labs Limited), CROMOLYN SODIUM (Preferred Pharmaceuticals), CROMOLYN SODIUM (Proficient Rx LP), CROMOLYN SODIUM (Proficient Rx LP), CROMOLYN SODIUM (RPK Pharmaceuticals), CROMOLYN SODIUM (Rising Pharma Holdings), CROMOLYN SODIUM (Sandoz), CROMOLYN SODIUM (Teva Pharmaceuticals USA), CROMOLYN SODIUM (Wallace Pharmaceuticals), CROMOLYN SODIUM (Woodward Pharma Services LLC), CROMOLYN SODIUM (Woodward Pharma Services LLC), CROMOLYN SODIUM INHALATION SOLUTION (Ritedose Pharmaceuticals), CROMOLYN SODIUM INHALATION SOLUTION (VIRTUS PHARMACEUTICALS LLC), CROMOLYN SODIUM ORAL SOLUTION (CONCENTRATE) (Ritedose Pharmaceuticals) |
|---|
| Formula |
C23H14O11. 2Na
|
|---|
| Exact mass |
512.0332
|
|---|
| Mol weight |
512.3302
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-allergic agent
DG01805 Mediator release inhibitor
|
|---|
| Remark |
| Product (DG00098): | D00526<JP/US> |
|
|---|
| Efficacy |
Antiallergic, Antiasthmatic, Chemical mediator release inhibitor |
|---|
| Comment |
Inhibition of Clc chloride channel
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EB Antiallergic agents, excl. corticosteroids
A07EB01 Cromoglicic acid
D00526 Cromolyn sodium (USP) <JP/US>
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AH Agents for dermatitis, excluding corticosteroids
D11AH03 Cromoglicic acid
D00526 Cromolyn sodium (USP) <JP/US>
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AC Antiallergic agents, excl. corticosteroids
R01AC01 Cromoglicic acid
D00526 Cromolyn sodium (USP) <JP/US>
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03BC Antiallergic agents, excl. corticosteroids
R03BC01 Cromoglicic acid
D00526 Cromolyn sodium (USP) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01G DECONGESTANTS AND ANTIALLERGICS
S01GX Other antiallergics
S01GX01 Cromoglicic acid
D00526 Cromolyn sodium (USP) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Cromolyn
D00526 Cromolyn sodium (USP)
Ophthalmic Agents
Ophthalmic Anti-allergy Agents
Mast Cell Stabilizer
Cromolyn
D00526 Cromolyn sodium (USP)
Respiratory Tract/Pulmonary Agents
Mast Cell Stabilizers
Cromolyn
D00526 Cromolyn sodium (USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D00526 Cromolyn sodium (USP); Sodium cromoglicate (JP18)
132 Otic and nasal agents
1329 Others
D00526 Cromolyn sodium (USP); Sodium cromoglicate (JP18)
2 Agents affecting individual organs
22 Respiratory organ agents
225 Bronchodilators
2259 Others
D00526 Cromolyn sodium (USP); Sodium cromoglicate (JP18)
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D00526 Cromolyn sodium (USP); Sodium cromoglicate (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Agents for ophthalmologic use
64 Allergy eye drops
D00526 Cromolyn sodium (USP)
Agents for otolaryngologic use
70 Nasal sprays for inflammation
D00526 Cromolyn sodium (USP)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Cromoglicic acid
D00526 Cromolyn sodium (USP)
Drug groups [BR:br08330]
Anti-allergic agent
DG01805 Mediator release inhibitor
DG00098 Cromoglicic acid
D00526 Cromolyn sodium
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00526 Sodium cromoglicate
Rx-to-OTC switch list in the USA [br08315.html]
D00526
Rx-to-OTC switch list in Japan [br08314.html]
D00526
Drug groups [BR:br08330]
Anti-allergic agent
DG01805 Mediator release inhibitor
DG00098 Cromoglicic acid
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 36
1 Z Na 4.4450 -7.9452 #+
2 Z Na 24.9023 -8.0156 #+
3 C8x C 8.9600 -6.5800
4 C8y C 8.9600 -7.9800
5 O2x O 10.1724 -8.6800
6 C8y C 11.3849 -7.9800
7 C8y C 11.3849 -6.5800
8 C8y C 10.1724 -5.8800
9 C8x C 12.5973 -8.6800
10 C8x C 13.8097 -7.9800
11 C8x C 13.8097 -6.5800
12 C8y C 12.5973 -5.8800
13 O1a O 15.0222 -5.8800
14 C1c C 15.0222 -4.4800
15 C1b C 13.8097 -3.7800
16 O2a O 12.5973 -4.4800
17 C8x C 16.2346 -6.5800
18 C8y C 17.4470 -5.8800
19 O2a O 17.4470 -4.4800
20 C1b C 16.2346 -3.7800
21 C8x C 16.2346 -7.9800
22 C8x C 17.4470 -8.6800
23 C8y C 18.6595 -7.9800
24 C8y C 18.6595 -6.5800
25 O2x O 19.8719 -8.6800
26 C8y C 21.0844 -7.9800
27 C8x C 21.0844 -6.5800
28 C8y C 19.8719 -5.8800
29 C6a C 22.2968 -8.6800
30 O6a O 23.5092 -7.9800 #-
31 O6a O 6.5351 -7.9800 #-
32 C6a C 7.7476 -8.6800
33 O6a O 7.7476 -10.0798
34 O5x O 10.1724 -4.4802
35 O5x O 19.8719 -4.4800
36 O6a O 22.2968 -10.0796
BOND 37
1 3 4 2
2 4 5 1
3 5 6 1
4 6 7 1
5 7 8 1
6 3 8 1
7 6 9 2
8 9 10 1
9 10 11 2
10 11 12 1
11 7 12 2
12 13 14 1
13 14 15 1
14 15 16 1
15 12 16 1
16 17 18 1
17 18 19 1
18 19 20 1
19 14 20 1
20 17 21 2
21 21 22 1
22 22 23 2
23 23 24 1
24 18 24 2
25 23 25 1
26 25 26 1
27 26 27 2
28 27 28 1
29 24 28 1
30 26 29 1
31 29 30 1
32 31 32 1
33 4 32 1
34 32 33 2
35 8 34 2
36 28 35 2
37 29 36 2
|
|---|
|
» Japanese version » Back
|
|